Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-11

FDA Approved: VENCLEXTA — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved the original application for VENCLEXTA (venetoclax) by AbbVie. The approval covers the treatment of chronic lymphocytic leukemia and small lymphocy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venclexta (venetoclax)

Snippet

ORIG AP for VENCLEXTA (VENETOCLAX)